Literature DB >> 17596739

Hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome.

Filip Van Den Eede1, Greta Moorkens, Boudewijn Van Houdenhove, Paul Cosyns, Stephan J Claes.   

Abstract

There is evidence for a hypofunction of the hypothalamic-pituitary-adrenal (HPA) axis in a proportion of the patients with chronic fatigue syndrome (CFS), despite the negative studies and methodological difficulties. In this review, we focus on challenge studies and on the role of the HPA axis in the pathogenesis of CFS. Mild hypocortisolism, blunted adrenocorticotropin response to stressors and enhanced negative feedback sensitivity to glucocorticoids are the main findings. Several underlying mechanisms have been proposed. Currently, it is a matter of debate whether these disturbances have a primary role in the pathogenesis of CFS. However, even if the HPA axis dysfunctions are secondary to other factors, they are probably a relevant factor in symptom propagation in CFS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17596739     DOI: 10.1159/000104468

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  29 in total

Review 1.  A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2012-06-21       Impact factor: 3.584

2.  Neuroendocrine correlates of childhood trauma in CFS.

Authors:  Filip Van Den Eede; Greta Moorkens
Journal:  Nat Rev Endocrinol       Date:  2012-07-10       Impact factor: 43.330

3.  Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Santiago Herrera; Wilfred C de Vega; David Ashbrook; Suzanne D Vernon; Patrick O McGowan
Journal:  Epigenetics       Date:  2018-12-05       Impact factor: 4.528

4.  Biological outcome measurements for behavioral interventions in multiple sclerosis.

Authors:  Anja Fischer; Christoph Heesen; Stefan M Gold
Journal:  Ther Adv Neurol Disord       Date:  2011-07       Impact factor: 6.570

5.  Convergent genomic studies identify association of GRIK2 and NPAS2 with chronic fatigue syndrome.

Authors:  Alicia K Smith; Hong Fang; Toni Whistler; Elizabeth R Unger; Mangalathu S Rajeevan
Journal:  Neuropsychobiology       Date:  2011-09-09       Impact factor: 2.328

Review 6.  Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation.

Authors:  Kevin G Burfeind; Vijayshree Yadav; Daniel L Marks
Journal:  Curr Neurol Neurosci Rep       Date:  2016-11       Impact factor: 5.081

7.  Prevalence of DSM-IV personality disorders in patients with chronic fatigue syndrome: a controlled study.

Authors:  Stefan Kempke; Filip Van Den Eede; Chris Schotte; Stephan Claes; Peter Van Wambeke; Boudewijn Van Houdenhove; Patrick Luyten
Journal:  Int J Behav Med       Date:  2013-06

8.  Fatigue and autonomic dysfunction in non-alcoholic fatty liver disease.

Authors:  Julia L Newton; Jessie Pairman; Katharine Wilton; David E J Jones; Christopher Day
Journal:  Clin Auton Res       Date:  2009-12       Impact factor: 4.435

9.  Model-based therapeutic correction of hypothalamic-pituitary-adrenal axis dysfunction.

Authors:  Amos Ben-Zvi; Suzanne D Vernon; Gordon Broderick
Journal:  PLoS Comput Biol       Date:  2009-01-23       Impact factor: 4.475

10.  Genetic variation in the hypothalamic-pituitary-adrenal stress axis influences susceptibility to musculoskeletal pain: results from the EPIFUND study.

Authors:  Kate L Holliday; Barbara I Nicholl; Gary J Macfarlane; Wendy Thomson; Kelly A Davies; John McBeth
Journal:  Ann Rheum Dis       Date:  2009-08-31       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.